Contact
Please use this form to send email to PR contact of this press release:
Angelini Pharma Presents Long-Term Data for cenobamateā¼ Demonstrating Benefit in Adults Living with Epilepsy
TO:
Chiara Antoniucci
Angelini Pharma
+39 3477133926